Bruce M. Cohen: An eclectic life and a multidisciplinary approach to the complex determinants and diverse presentations of psychiatric disorders

Bruce M. Cohen, MD, PhD, stands as one of psychiatry's most innovative research leaders, transforming our understanding of neuropsychiatric disorders through groundbreaking multidisciplinary approaches at McLean Hospital and Harvard Medical School. As Robertson-Steele Professor of Psychiatry at Harvard and Director of the Program for Neuropsychiatric Research at McLean Hospital, Dr. Cohen has pioneered revolutionary techniques combining brain imaging, genomics, and induced pluripotent stem cell models to unlock the complex biological mechanisms underlying schizophrenia, bipolar disorder, and Alzheimer's disease. With over 400 peer-reviewed publications and five awarded patents spanning nearly five decades at McLean, his discoveries in mitochondrial dysfunction and energy metabolism abnormalities have opened unprecedented therapeutic pathways. His laboratory's cutting-edge ability to grow brain cells from patient samples represents what he describes as technology "giving us leads we did not have forty years ago." Named Psychiatrist of the Year twice by the National Alliance on Mental Illness of Massachusetts, Dr. Cohen's impact extends beyond research to institutional transformation. As McLean's President from 1997 to 2005, he reversed the hospital's financial decline, establishing over 30 new programs while achieving record levels of patient care, research funding, and educational training. His current work challenges century-old psychiatric diagnostic models with evidence-based dimensional approaches that better capture the complexity of mental illness. In this comprehensive Genomic Press Interview, Dr. Cohen shares insights from his remarkable journey from molecular genetics at MIT and Case Western to becoming a leading voice advocating for the replacement of stigmatizing terms like "schizophrenia" with scientifically accurate alternatives, while revealing the personal experiences and intellectual curiosity that have driven his dedication to understanding and treating the most challenging neuropsychiatric conditions.